This is a 55-year-old female with a history of diabetes mellitus type 2 (DMII) who was admitted for recurrent left lower extremity (LE) ulcerations and cellulitis of the right foot. She was treated with IV Unasyn for 5 days and switched to Linezolid 600MG PO BID as an outpatient medication. COUMADIN (WARFARIN SODIUM) 5MG PO QPM, NEXIUM (ESOMEPRAZOLE) 20MG PO QD, ACETYLSALICYLIC ACID 325MG PO QD, SIMVASTATIN 20MG PO QHS, GLYBURIDE 2.5MG PO QD HOLD IF: NPO, LISINOPRIL 10MG PO QD HOLD IF: SBP<95, SARNA TOPICAL TP QD, MICONAZOLE NITRATE 2% POWDER TOPICAL TP BID were prescribed. POTENTIALLY SERIOUS INTERACTIONS: WARFARIN & CIPROFLOXACIN, WARFARIN & SIMVASTATIN, WARFARIN & ASPIRIN, LISINOPRIL & POTASSIUM CHLORIDE Reason for override: as needed were noted. Bone scan and plain films from prior hospitalizations were consulted and Instructions for bilateral lower extremity rash were given. She was discharged on 7/15/05 with disposition home and diet with no restrictions, told to resume regular exercise and arrange INR to be drawn on 10/13/05 with follow-up INR's to be drawn every 7 days.
has there been a prior linezolid
Linezolid 600MG PO BID